Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.65 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.65 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.65 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.65 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.65 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.65 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.65 |
| ▸ | HTR1A | P08908 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.65 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.65 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.65 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13346043 | 0.91 | GAA (0.65) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL14045415 | 0.88 | CHRM1 (0.64) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL780253 | 0.88 | ADRA2A (0.64) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL28294723 | 0.86 | ADRA2A (0.61) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Hydrochloric Acid SCHEMBL28127021 | 0.86 | MAPT (0.65) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL16684872 | 0.84 | ADRA2A (0.59) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL41537 | 0.84 | ADRA2A (1.00) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL356673 | 0.84 | ADRA2A (0.73) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL25099005 | 0.83 | ADRA2A (0.57) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL1643328 | 0.82 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114044852-B | Polymerizable eutectic solvent, conductive elastomer and preparation method of conductive elastomer | 江南大学 | 2022-11-22 | — | — | CN | claimed |
| CN-114044852-A | Polymerizable eutectic solvent, conductive elastomer and preparation method thereof | 江南大学 | 2022-02-15 | — | — | CN | claimed |
| US-12440438-B2 | Method of remotely controlling pain | Novilla Pharmaceuticals, Inc. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-3503927-B1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | UNIV CALIFORNIA (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20240156964-A1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE ARIZONA BOARD OF REGENTS | 2024-05-16 | — | — | US | disclosed |
| US-11786597-B2 | Ionic liquids for transdermal drug delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230310528-A1 | DEEP EUTECTIC SOLVENT INCLUDING ONE OR MORE ACTIVE PHARMACEUTICAL INGREDIENTS DERIVED FROM MUSHROOMS | OPTIMI HEALTH CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| US-11720018-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| CN-109789216-B | Topical skin treatment formulations based on ionic species | 加利福尼亚大学董事会 | 2023-05-23 | — | — | CN | disclosed |
| US-20230152692-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230152692-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20190192661-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-06-27 | — | — | US | disclosed |
| US-20180143532-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-05-24 | — | — | US | disclosed |
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| WO-2018044920-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-03-08 | — | — | WO | disclosed |
| US-20160263225-A1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE ARIZONA BOARD OF REGENTS | 2016-09-15 | — | — | US | disclosed |
| EP-3062819-A2 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | The Regents of The University of California (US) | 2016-09-07 | — | — | EP | disclosed |
| WO-2015066647-A9 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015066647-A2 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-05-07 | — | — | WO | disclosed |
| US-20140377706-A1 | DEVELOPER FOR PHOTOSENSITIVE RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190192661-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | CUTA, KRT18, SLC38A7 | ADRA2A 4623/4885ADRA1A 4246/4885MAPT 2382/4885 |
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SLC9A1, FN1, EPCAM | ADRA2A 3217/4885ADRA1A 1359/4885MAPT 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.